Newsroom - Page 3

Mice administered FOLFIRINOX through the implantable device had greater tumor regression and lower tissue toxicity.
What we're reading, February 10, 2016: 2 companies change how consumers purchase medicines online; CMS memo reveals the government is mulling changes to Medicare reimbursement; and Johns Hopkins will transplant HIV-positive organs to HIV-positive recipients.
As physicians and researchers question whether certain treatments for early signs of breast cancer are necessary, the first large US study will seek to determine the best way to manage ductal carcinoma in situ.
Innovation has remained high on the administration’s agenda, as is evident from the allocations to tackle climate changes as well as find treatments for devastating health conditions.
CMS has already delayed Medicaid managed care once, pushing the start date back to at least March 1, 2016.
A. Mark Fendrick, MD, co-editor-in-chief of The American Journal of Managed Care and director of the University of Michigan Center for Value-Based Insurance Design, testified before a Michigan senate subcommittee on the benefit of clinical nuance.
Mexico is the perfect example of how Coke and Pepsi are investing heavily in the next generation of soda drinkers, and the country has the highest rates of obesity in the world.
An investigation of why efforts to improve maternal health in the United States are lagging, and what action must be taken to lower maternal mortality.
Diabetes Compendium
Oncology Compendium
COPD Compendium
Reimbursement Compendium